Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Biofinderon Jun 06, 2018 12:19pm

161 Views

Post# 28132737

RE:RE:RE:RE:RE:RE:RE:60 days or less for final marketing approval?

Your strategy of “Deflection” and “Projection” isn’t working for you, as evidenced by the skyrocketing “ignores” you’ve accumulated. Few believe you, and fewer still are listening to you. Take the hint. Being illiterate and stupid is no way to go through life.

GunnerG wrote: First you blame PL for your inflated numbers and pulling back of dates, call him a liar; now you deflect to your disappointment in the FDA.

$8 billion, $15 billion; PL is a liar, FDA disappointing. Your all over the board.

Senile = showing a decline or deterioration of mental functioning, especially short-term memory and alertness, as a result of old age or disease.

Biofinder wrote: N I

rcdoggy wrote: Bio....strong language re PL "liar"! I and many others are just as frustrated as you, maybe more as we have been around a very long time with this company. I agree that Pierre is a great salesman and every company needs them but liar. Would like to hear what it is specifically he lied about regarding Ryplazim. Cheers

How about, lie = mislead = misspoken = wishful thinking. Not really disappointed in PL, more disappointed in the FDA and the way they handle themselves; Prometic is not the first and probably not the last. But that’s okay, I can easily wait for 2020 when I believe it all comes together for Prometic.